Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec;9(4):261-264.
doi: 10.1055/s-0040-1710057. Epub 2020 Apr 24.

Impact of Helium-Oxygen Administered via High Velocity Nasal Insufflation on Delivery of Inhaled Nitric Oxide

James H Hertzog  1   2   3 , Katlyn L Burr  1 , Angela Stump  1 , Joel M Brown  1 , Scott Penfil  4 , Kimberly McMahon  2   3
Affiliations

Impact of Helium-Oxygen Administered via High Velocity Nasal Insufflation on Delivery of Inhaled Nitric Oxide

James H Hertzog et al. J Pediatr Intensive Care. 2020 Dec.

Abstract

Inhaled nitric oxide (iNO) may be continued during the transition from invasive to noninvasive respiratory support. Upper airway obstruction from laryngeal edema following extubation and lower airway obstruction from asthma and bronchiolitis may be managed with inhaled helium. The coadministration of helium with iNO and the impact on delivered amounts of iNO have not been extensively studied. A bench model simulating a spontaneously breathing infant received iNO at varying preset doses delivered with either helium-oxygen or nitrogen-oxygen via a Vapotherm unit. iNO levels were measured at the simulated trachea. Results from the two conditions were compared using t-tests. When nitrogen-oxygen was used, there was no difference between preset and measured iNO levels. A significant difference was present when helium-oxygen was used, with a 10-fold increase in measured iNO levels compared with preset values. The use of helium resulted in a significant increase in measured iNO at the level of the simulated trachea. Clinicians must be aware that iNO will not be delivered at prescribed doses when used with helium under the conditions used in this study.

Keywords: high flow nasal cannula; high velocity nasal insufflation; inhaled nitric oxide.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest K.B. is associated as a Patient Trainer, Hill-Rom. No conflicts of interest, financial or otherwise, exist for J. H. H., A. S., J. M. B., S. P., and K. M.

Figures

Fig. 1
Fig. 1
Inhaled nitric oxide measurements. PPM, parts per million.
See this image and copyright information in PMC

References

    1. Dalton H J. Inhaled nitric oxide: medical miracle or passing fad? Respir Care. 1998;43:978–987.
    1. DiBlasi R M, Dupras D, Kearney C, Costa E, Jr, Griebel J L. Nitric oxide delivery by neonatal noninvasive respiratory support devices. Respir Care. 2015;60(02):219–230. - PubMed
    1. Baudin F, Gagnon S, Crulli B, Proulx F, Jouvet P, Emeriaud G. Modalities and complications associated with the use of high-flow nasal cannula: experience in a pediatric ICU. Respir Care. 2016;61(10):1305–1310. - PubMed
    1. Tremblay J A, Couture E J, Albert M. Noninvasive administration of inhaled nitric oxide and its hemodynamic effects in patients with acute right ventricular dysfunction. J Cardiothorac Vasc Anesth. 2019;33(03):642–647. - PubMed
    1. Tominaga Y, Iwai S, Yamauchi S. Post-extubation inhaled nitric oxide therapy via high-flow nasal cannula after Fontan procedure. Pediatr Cardiol. 2019;40(05):1064–1071. - PubMed